Protalix Biotherapeutics Inc. (PLX)
NYSE · Healthcare
Protalix Biotherapeutics Inc. PS Ratio 2006–2026
Current and historical P/S ratio for Protalix Biotherapeutics Inc. (PLX): market cap divided by trailing twelve-month revenue. As of March 31, 2026 it is 2.33.
From: 06/30/2011To: 03/31/2026
Stock Price
TTM Revenue
PS Ratio
Protalix Biotherapeutics Inc. PS Ratio — FAQ
Protalix Biotherapeutics Inc. (PLX) ps ratio over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PLX's ps ratio history?
The chart and table above show Protalix Biotherapeutics Inc.'s ps ratio by year and by quarter, including the growth rate.